Chloé Sauzay

956 total citations
19 papers, 671 citations indexed

About

Chloé Sauzay is a scholar working on Cell Biology, Oncology and Molecular Biology. According to data from OpenAlex, Chloé Sauzay has authored 19 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cell Biology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Chloé Sauzay's work include Endoplasmic Reticulum Stress and Disease (8 papers), Autophagy in Disease and Therapy (5 papers) and Drug Transport and Resistance Mechanisms (2 papers). Chloé Sauzay is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (8 papers), Autophagy in Disease and Therapy (5 papers) and Drug Transport and Resistance Mechanisms (2 papers). Chloé Sauzay collaborates with scholars based in France, Greece and United States. Chloé Sauzay's co-authors include Antoine Galmiche, Bruno Chauffert, Aline Houessinon, Jean‐Claude Barbare, Éric Chevet, Tony Avril, Zuzana Saidak, Aristotelis Chatziioannou, Christophe Louandre and Konstantinos Voutetakis and has published in prestigious journals such as Molecular Cancer, Cancer Letters and Clinica Chimica Acta.

In The Last Decade

Chloé Sauzay

19 papers receiving 665 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chloé Sauzay 329 204 160 150 118 19 671
Fuchen Liu 373 1.1× 235 1.2× 124 0.8× 108 0.7× 49 0.4× 51 727
Sorin Armeanu–Ebinger 467 1.4× 203 1.0× 105 0.7× 241 1.6× 164 1.4× 45 895
Yulin Sun 649 2.0× 375 1.8× 163 1.0× 231 1.5× 94 0.8× 56 1.0k
Shamir Cassim 407 1.2× 281 1.4× 104 0.7× 149 1.0× 36 0.3× 17 696
Aimin Huang 448 1.4× 207 1.0× 83 0.5× 194 1.3× 50 0.4× 61 856
Alisha M. Mendonsa 478 1.5× 227 1.1× 89 0.6× 268 1.8× 138 1.2× 8 865
Peiguo Cao 581 1.8× 496 2.4× 130 0.8× 168 1.1× 68 0.6× 58 878
Leping Yang 398 1.2× 229 1.1× 108 0.7× 195 1.3× 32 0.3× 41 725
Haohai Zhang 372 1.1× 291 1.4× 130 0.8× 201 1.3× 33 0.3× 27 784
Yanyan Shen 824 2.5× 293 1.4× 138 0.9× 219 1.5× 48 0.4× 63 1.2k

Countries citing papers authored by Chloé Sauzay

Since Specialization
Citations

This map shows the geographic impact of Chloé Sauzay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé Sauzay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé Sauzay more than expected).

Fields of papers citing papers by Chloé Sauzay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé Sauzay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé Sauzay. The network helps show where Chloé Sauzay may publish in the future.

Co-authorship network of co-authors of Chloé Sauzay

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé Sauzay. A scholar is included among the top collaborators of Chloé Sauzay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé Sauzay. Chloé Sauzay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Doultsinos, Dimitrios, Raphaël Pineau, Chloé Sauzay, et al.. (2023). A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment. iScience. 26(5). 106687–106687. 22 indexed citations
3.
Sauzay, Chloé, J. Schmidt, Christophe Louandre, et al.. (2021). Analysis of Mesencephalic Astrocyte-derived Neurotrophic Factor in Multiple Myeloma. Anticancer Research. 41(9). 4305–4312. 2 indexed citations
4.
Houessinon, Aline, J. Bettoni, Chloé Sauzay, et al.. (2020). Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases. Case Reports in Oncology. 13(2). 835–842. 1 indexed citations
5.
Sauzay, Chloé, et al.. (2019). Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion. Cancers. 11(5). 631–631. 72 indexed citations
6.
Sauzay, Chloé, Konstantinos Voutetakis, Aristotelis Chatziioannou, Éric Chevet, & Tony Avril. (2019). CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule. Frontiers in Cell and Developmental Biology. 7. 66–66. 72 indexed citations
7.
Saidak, Zuzana, Denis Chatelain, Chloé Sauzay, et al.. (2018). Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours. Anticancer Research. 38(3). 1343–1352. 12 indexed citations
8.
Sauzay, Chloé, Christophe Louandre, Sandra Bodeau, et al.. (2018). Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells. Oncotarget. 9(9). 8400–8414. 33 indexed citations
9.
Godin, Corinne, Sandra Bodeau, Zuzana Saidak, et al.. (2018). Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma. Oncology Reports. 41(3). 2041–2050. 7 indexed citations
10.
Saidak, Zuzana, Christophe Louandre, Chloé Sauzay, et al.. (2018). A pan-cancer study of the transcriptional regulation of uricogenesis in human tumours: pathological and pharmacological correlates. Bioscience Reports. 38(5). 8 indexed citations
11.
Bodeau, Sandra, Chloé Sauzay, Rémy Nyga, et al.. (2017). Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A. Anticancer Research. 37(3). 1049–1058. 5 indexed citations
13.
Houessinon, Aline, Chloé Sauzay, Christophe Louandre, et al.. (2016). Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. Molecular Cancer. 15(1). 38–38. 116 indexed citations
14.
Vieillard, Victoire, A. Astier, Chloé Sauzay, & Muriel Paul. (2016). One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 °C and 25 °C. Annales Pharmaceutiques Françaises. 75(1). 17–29. 17 indexed citations
15.
Galmiche, Antoine, Chloé Sauzay, Aline Houessinon, Bruno Chauffert, & Olivier Pluquet. (2016). Probing Tumour Proteostasis and the UPR with Serum Markers. Trends in cancer. 2(5). 219–221. 5 indexed citations
16.
Sauzay, Chloé, Mélanie White‐Koning, Isabelle Hennebelle, et al.. (2016). Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacological Research. 110. 89–95. 29 indexed citations
17.
Sauzay, Chloé, et al.. (2016). Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clinica Chimica Acta. 463. 39–44. 210 indexed citations
18.
Galmiche, Antoine, Chloé Sauzay, Éric Chevet, & Olivier Pluquet. (2016). Role of the unfolded protein response in tumor cell characteristics and cancer outcome. Current Opinion in Oncology. 29(1). 41–47. 26 indexed citations
19.
Bihan, Kévin, Chloé Sauzay, Lauriane Goldwirt, et al.. (2014). Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of Vemurafenib in Human Plasma. Therapeutic Drug Monitoring. 37(1). 132–136. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026